Nothing Special   »   [go: up one dir, main page]

show episodes
 
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
  continue reading
 
Artwork

1
The Future of Pharma

Samir Gondalia, ISPE Boston

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
The Future of Pharma with ISPE Boston. Find out where the pharmaceutical industry is headed and what it means for you. Join host Samir Gondalia as he chats with the thought leaders of the pharma world about the new technologies, innovative applications and emerging markets and how it’s going to influence the future of Pharma.
  continue reading
 
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
  continue reading
 
Discover the transformative power of GenAI, Data Analytics, Social Intelligence, and Physician Influencer Marketing that is shaping the future of pharma marketing. Join us, as we pave the pathway to a novel pharma marketing landscape, bringing to you conversations that meet at the intersection of technology and marketing. Hosted by Saumya Prakash, Co-Founder Multiplier AI Solutions, this podcast is spearheading the dialogues on disruptions in pharma marketing. Know more about us at: https:// ...
  continue reading
 
I'm passionate about helping pharma field teams feel confident using technology to engage with healthcare professionals. I want them to feel good about themselves and achieve amazing results. To explore this topic, I've been interviewing inspiring pharma leaders to learn from them for this Digital Transformation Series. - Mehrnaz Campbell, Founder and CEO of Cheemia & Cheemia ReSET Author of The Omni Advantage
  continue reading
 
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
  continue reading
 
Artwork

1
Dose of Pharma

Dose of Pharma

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
There are a million and one science podcasts out there but none of them are quite like Dose of Pharma! Made for students, by students, we provide you with bite-sized doses of discussions on all sorts of science content, personal development, student life, and STEM careers. With a nugget of wisdom available for you to take away from each episode, you’ll be glad you decided to embrace your inner nerd and start listening to us!
  continue reading
 
Artwork
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Artwork
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
Artwork
 
Welcome to the International Pharma Talks, powered by ELS Solutions Group, a podcast hosted by Dr. Diogo Sousa-Martins, Ph.D., MBA. This podcast will dive deep into the world of pharma & healthcare international business where you will learn strategies and action plans to help you navigate through your internationalization program and achieve the best results. If you wish to develop your international program in pharma, healthcare or medtech areas or to register or distribute your products i ...
  continue reading
 
Artwork

1
Digital Pathology Podcast

Aleksandra Zuraw, DVM, PhD

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
  continue reading
 
Artwork
 
American Healthcare Entrepreneurs and Execs you might want to know. Talking. Relentless Health Value is a weekly interview podcast hosted by Stacey Richter, a healthcare entrepreneur celebrating fifteen years in the business side of healthcare. This show is for leaders in pharma, devices, payers, providers, patient advocacy and healthcare business. It's for health industry innovators, entrepreneurs or wantrepreneurs or intrapreneurs. Relentless Healthcare Value is the show for you if you wan ...
  continue reading
 
Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to li ...
  continue reading
 
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-liste ...
  continue reading
 
Artwork

1
Pharmaverse Podcast

Michael Pietrack

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
The Pharmaverse is a leadership podcast that brings you exclusive insights from the stars of the Pharma universe. Hosted by Michael Pietrack, a top Pharma and Biotech recruiter, whose team partners with the most recognizable Pharma companies in the industry, as well as the hottest of the emerging Biotechs. In each episode, Michael sits down with influential and innovative leaders in the Pharmaceutical and related industries. Listeners will hear from stars from all sectors of the Pharmaverse ...
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Artwork

1
The Top Line

Fierce Life Sciences

icon
Unsubscribe
icon
Unsubscribe
Weekly
 
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
  continue reading
 
Artwork
 
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
  continue reading
 
Artwork

1
Pathways in Life Science

North Star Scientific Inc.

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
We dive into the stories of people shaping life sciences and biotech. Each episode highlights scientists, professionals from the lab to the boardroom, entrepreneurs, and innovators—their career twists, key decisions, and impact. It’s packed with insights, advice, and inspiration for anyone curious about science-driven careers making a difference.
  continue reading
 
Science Will Win is a podcast that takes listeners under the microscope on some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating scie ...
  continue reading
 
Just a spoonful of humor helps the medicine go down. Inspired by his brother’s suicide David unleashes his outlandish banter and passion for mental health with his good friends and experts alike. He challenges the over-medicated status quo, asking questions and exploring new holistic alternatives with his guests from a wide array of experience and discipline.
  continue reading
 
News of the mysterious deaths of billionaire Canadian pharma giant Barry Sherman and his philanthropist wife Honey in December 2017 reverberated around the world. Five years later, with no arrests and little news from the police, their deaths remain shrouded in mystery and conspiracy theories, with too many lingering questions. Not just who killed them, but what kind of life do you have to live that when you’re found dead, there are multiple theories, including some involving your own family ...
  continue reading
 
Artwork

1
DarshanTalks Podcast

Darshan Kulkarni

icon
Unsubscribe
icon
Unsubscribe
Weekly+
 
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues ...
  continue reading
 
Artwork

1
Not Just Patients

Caitlin and Clarinda

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Hello and welcome to Not Just Patients, a podcast where we break barriers to meaningful patient involvement in healthcare. We’re your hosts, Caitlin Rich and Clarinda Cerejo. We’re both rare disease patients and qualified patient experts. And we are so much more. Join us and our guests as we challenge patient stereotypes, highlight successful collaborations in healthcare, and share energizing tales of turning adversity into advocacy.
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Artwork

1
Bohemia Pharma

Bohemia Pharma

icon
Unsubscribe
icon
Unsubscribe
Daily+
 
At BohemiaPharma, we offer a range of high-quality addiction treatment medications designed to support recovery from substance abuse. Our clinically proven treatments help manage withdrawal symptoms and reduce cravings, providing a solid foundation for a healthier, addiction-free life.
  continue reading
 
Artwork

1
SCAN/STORIES

GS1 Healthcare

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
Discover how GS1 standards and barcodes transform healthcare through stories, expert insights, and conversations that spotlight medical product traceability, supply chain innovation and patient safety. Hosted by Mia, an AI-created voice, each episode delivers practical knowledge and inspiration for a safer and smarter healthcare system.
  continue reading
 
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape. Welcome to Talk Radioisotopes: Going Nuclear on Cancer. We’ll take a look at the latest insights, trends and developments working to change patient outcomes and supply the fight against cancer ...
  continue reading
 
Driving the Business of Science is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world. Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step. In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insig ...
  continue reading
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
  continue reading
 
Artwork

1
Modern Wisdom

Chris Williamson

icon
Unsubscribe
icon
Unsubscribe
Weekly+
 
Life is hard. This podcast will help. Lessons from the greatest thinkers on the planet with Chris Williamson. Including guests like David Goggins, Dr Jordan Peterson, Sam Harris, Jocko Willink, Dr Andrew Huberman, Dr Julie Smith, Steven Bartlett, Ryan Holiday, James Clear, Robert Greene, Matthew McConaughey, Steven Pinker, Alex Hormozi, Douglas Murray, Chris Bumstead, Mark Manson and more.
  continue reading
 
A podcast on statistical science and clinical trials. Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailored for pharma pioneers. Featuring expertise from industry leaders, each episode is crafted to pro ...
  continue reading
 
Artwork

1
MPR Weekly Dose

MPR Weekly Dose

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news.
  continue reading
 
Loading …
show series
 
After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companies, manufacturers and other outfits across the life sciences spectrum are still scrambling to respond to mounting trade pressures. While many unknowns remain, biopharma companies should waste no time in starting to evaluate their o…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Eli Lilly's shares surged 11% after their obesity pill, orforglipron, showed "injectable-like efficacy" in a phase III diabetes trial. The drug achieved significant reductions in body weight and improvements in glucose co…
  continue reading
 
My guest in this episode is Vinay Patel. Vinay is a pharmacist executive with over 18 years in the field and founder of MakoRx. He has been involved with health management, community pharmacy operations, and creating pharmacy services. Vinay has worked in various pharmacy settings including national retail, local community, hospital pharmacy, acade…
  continue reading
 
In this episode of Let's Combinate, host Subhi Saadeh welcomes back Skip Creveling, a global expert in program management and Six Sigma methodologies. Skip shares his extensive experience helping Fortune 500 companies optimize design processes, reduce risks, and drive innovation—especially in highly regulated industries like medical devices, pharma…
  continue reading
 
In this must-listen episode, Dr. Andre Bates sits down with Soner Hacihaliloglu, founder and CEO of PONS Tech, to explore how Generative AI (GenAI) and ultrasound technology are combining to radically improve medical imaging, early detection, and preventive healthcare. 🚀 Key Takeaways: How AI-driven image enhancement is solving the challenges of lo…
  continue reading
 
Welcome to another episode of 'Pharma Marketing Playbook' where we delve into the latest strategies in pharmaceutical marketing, data analytics, and AI trends. In this episode, we sit down with Jyoti Patil Shah, CEO of V Care Foundation, who brings her vast experience in psychology, counseling, and patient advocacy. Jyoti shares her journey from co…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week: The good — Novartis to invest $23B in U.S. manufacturing and R&D, including seven new sites The bad — U.S. urged to invest $15B to counter China’s biotech rise The ugly — Trump signals ‘major’ tariffs on pharm…
  continue reading
 
In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant. Emet is a pharmacist by training. She shares her insights on the importance of t…
  continue reading
 
In this episode of the Digital Transformation Series, Mehrnaz chatted with Andrew Binns, Global Marketing Director of Croda Pharma. Andrew Binns began his marketing career working with English Premier League football clubs and major tourist boards, including Visit Britain and Visit California. In these roles, he developed a deep understanding of au…
  continue reading
 
In this episode, Ayesha spoke with Carlos Martin, MBA, chief commercial operations and revenue officer at Rocket Pharmaceuticals, a company developing gene therapy cures for rare diseases through innovative science and platforms. Carlos joined Rocket in April 2021 and established the company’s early commercial strategy and infrastructure as Chief C…
  continue reading
 
Join Isabel and Jade as they wrap up Season 9 of the podcast with special guest Dennise Broderick, President and Managing Director, Galen Pharma. In this episode, Jade and Dennise discuss her move from academia to the pharmaceutical industry, her lifelong ambition to be a leader and how she approaches hard decisions in business. A little more on EM…
  continue reading
 
The field of mental health has long been plagued by stigma, limited treatment options, and a lack of understanding of the human mind. However, recent advancements in neuroscience and a resurgence of interest in psychedelic substances are challenging traditional paradigms, offering new hope for those suffering from mental health disorders. Psychedel…
  continue reading
 
The FDA you designed your protocol around may no longer exist. In this episode, Darshan Kulkarni breaks down why clinical researchers, regulatory attorneys, and promotional review teams need to pay attention—now. With mass layoffs, frozen guidances, and a reorganization shaking CDER and CBER to their core, trial timelines, IRB reliance, and even le…
  continue reading
 
Pfizer ends danuglipron clinical program for obesity; FDA warns about counterfeit Ozempic; daily pill shows promise in reducing HbA1c; mavacamten misses in nonobstructive HCM trial and the FDA clears smart belt device reduce fall injury.
  continue reading
 
Send us a text In this episode of the Digital Pathology Podcast, I sit down with Dr. Yuri Nikiforov, founder of the World Tumor Registry, to explore how this global, open-access whole slide image platform contributes to cancer diagnostics, education, and research. We talk about how the registry allows pathologists, researchers, and patients to view…
  continue reading
 
Summary:At the heart of any successful self-care business is a portfolio of recognizable and trusted consumer health brands. These brands could play a key role in unlocking the potential of digital self-care in the UK, suggests Michelle Riddalls, in this second part of her Over the Counter interview. As PAGB CEO, Michelle has seen first had how the…
  continue reading
 
So, let’s continue themes from prior episodes, most particularly the episode from last week with Christine Hale, MD, MBA (EP471), which was also about high-cost claimants and just the impact that they have on the wallets of self-insured employers and any other plan sponsor. For a full transcript of this episode, click here. If you enjoy this podcas…
  continue reading
 
Rob Henderson holds a PhD in psychology from the University of Cambridge and is a Senior Fellow at the Manhattan Institute. Who holds the power in modern dating? With growing gender divides and political polarization, it’s no wonder dating feels harder than ever. So, how did we get here, and what’s the way forward? Expect to learn why political div…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Trump has signaled support for removing the IRA's 'pill penalty', with analysts cautiously optimistic about the executive order. Tariffs are in focus as Q1 earnings get underway, with EU and US pharmas making demands of t…
  continue reading
 
Across the life sciences, Regulatory Affairs (RA) teams and their colleagues in Quality and Safety are stretched beyond their limits as already impossible demands on their time are compounded by rising health authority expectations. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celege…
  continue reading
 
The FDA is facing unprecedented turmoil—staff cuts, a sweeping reorganization, and political interference are undermining its ability to safeguard public health. Former agency leaders are raising red flags, with one likening the situation to "flat earthers taking over NASA." With vaccine data access becoming politicized, stem cell oversight potenti…
  continue reading
 
In this episode, Ayesha spoke with Marc Hedrick, MD, MBA, president and CEO of Plus Therapeutics, a company focused on developing a novel class of targeted radiotherapeutics. Prior to heading Plus Therapeutics, Dr. Hedrick served in a number of executive leadership roles including president, CEO and director at Cytori Therapeutics, and president an…
  continue reading
 
Over the last five years, the healthcare industry has witnessed an explosive surge in digital health services, revolutionizing the way we access medical care. Patients today are taking charge of their health journey by using different digital tools to stay on top of their preventative screenings, implement dietary and lifestyle changes, access ment…
  continue reading
 
While cancer deaths in the United States have declined in recent years, some populations are being left behind—facing complicated challenges to accessing the care they need. Intervening at the earliest stages of disease onset is critical to cancer treatment success and to reducing the risk of recurrence. So how do we create a world where all people…
  continue reading
 
Podcasting has become essential for communicating breakthroughs in science, offering an accessible and engaging platform to reach diverse audiences. This evolving medium fosters deeper connections by delivering trusted information in accessible and compelling ways. In this conversation, audio makers from Pfizer, Acast, and TED, discuss what it take…
  continue reading
 
On this episode, hosts Scott and Sarah are joined by Matt Furlow, Associate Principal at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering and a decade of consulting experience, Matt brings a unique perspective on how scientific insight and strategic planning intersect to help biotech and pharma companies…
  continue reading
 
In this episode of Careers in Discovery, Tom meets with Annelise Vuidepot, Chief Technology Officer and UK Site Head at Immunocore, one of the UK’s most successful Biotech companies. Annelise was there on day one in 2000, when Immunocore spun out from Oxford University, and she’s been at the heart of the company’s pioneering work in T-cell receptor…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Trump has opened a national security probe on pharmaceutical imports, potentially leading to tariffs on these products. Johnson & Johnson reported strong earnings in Q1 thanks to certain drugs, while a phase III…
  continue reading
 
In a new pharmaphorum podcast, recorded during Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine, about the role of prevention in the future of healthcare. Recorded onsite at The Eden Project in Cornwall, the conversation centred around the Adelphi Group-sponsored panel, ‘The Preve…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Pfizer has dropped its lead obesity molecule, danuglipron, due to safety concerns regarding liver issues, leaving the company with only one molecule in its obesity pipeline. This decision has raised questions about the futu…
  continue reading
 
In this episode, Kate Woods and Darshan Kulkarni discussed the shift from employer-sponsored health insurance to individual responsibility, a transition accelerated by policy changes and rising healthcare costs. Traditionally, employer-provided insurance has been the backbone of the U.S. healthcare system, but evolving regulations, including the Af…
  continue reading
 
In celebration of our First Anniversary at Not Just Patients, we hosted a very special LinkedIn LIVE Podcast Takeover with Guest Host Joel Nelson on World Health Day, the 7th of April 2025. An award-winning patient advocate who uses his story of psoriatic-associated juvenile idiopathic arthritis to inspire change, Joel is the Founder of Psoriatic D…
  continue reading
 
We love to hear from our listeners. Send us a message. On today's episode we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to lead teams, especially when those teams have deeper subject matter expertise. Other topics discussed include when to make …
  continue reading
 
In this episode of "In the Interim...," Scott Berry and Kert Viele navigate the nuanced debate surrounding the integration of external data in clinical trials. Discover the implications and potential benefits and pitfalls of leveraging historical and real-world evidence in the analysis of clinical trials. Key Highlights: • Exploration of how extern…
  continue reading
 
Douglas Murray is a journalist, author and associate editor of The Spectator. Some see The West in decline, others believe we're entering a bold, uncharted era of opportunity. So how do we preserve the foundations of the West while also protecting the cultural values that make it worth saving? Expect to learn what Douglas thinks of Trump's first fe…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Lawmakers are focusing on boosting the US biotech industry while keeping China's growth in check. Novartis plans to invest $23 billion in US operations, potentially creating up to 1,000 new jobs. The FDA is exploring the us…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 April 2025. In this episode: Trump’s tariff rollercoaster; regulatory, economic uncertainties hang over Q1 earnings; IPOs rise in Q1 but may slow; Chinese deal-making matures; and AstraZeneca talks about Chinese innovation. https://insights.citeline.com/…
  continue reading
 
When mergers and acquisitions intersect with clinical trials, due diligence becomes a crucial step in ensuring a successful transition. In this insightful discussion, Darshan Kulkarni and Edye Edens explore the key legal and operational considerations when acquiring or merging with clinical research entities, including sponsors, sites, and CROs. A …
  continue reading
 
Annaka Harris is an author, editor, and speaker focused on neuroscience and consciousness. What does it mean to be conscious? What is consciousness? These questions have puzzled humanity for millennia. Despite our greatest scientific breakthroughs and philosophical efforts, are we any closer to understanding the origins and true nature of conscious…
  continue reading
 
As regulatory expectations evolve under the FDA’s Project Optimus oncology dosing initiative, biostatistics is emerging as a central pillar in designing and executing trials that move beyond the traditional maximum tolerated dose (MTD) approach. In this fourth episode of our Project Optimus series, host Dr. Wael Harb is joined by biostatistics expe…
  continue reading
 
Uplizna gains new indication; Vanrafia approved for proteinuria in IgAN; Erzofri now available for schizophrenia; setmelanotide shows promise in hypothalamic obesity; GLP-1RAs may reduce dementia risk.By Steve Duffy
  continue reading
 
In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson discuss how workforce reductions impacted the biopharma industry in the first quarter. The pair examine industry trends, company closures, developments in the cell and gene space—and the reductions in force happening at feder…
  continue reading
 
Send us a text In this episode of the Digital Pathology Podcast, I explore the ethical and bias considerations in AI and machine learning through the lens of pathology. This is part six of our special seven-part series based on the landmark Modern Pathology review co-authored by the UPMC group, including Matthew Hanna, Liam Pantanowitz, and Hooman …
  continue reading
 
미국이 수입 의약품에 관세를 부과할 가능성은 여전하지만, 트럼프의 최근 발표로 인해 이를 시행하는 데 시간이 더 걸릴 수 있다는 Pink Sheet (Citeline Regulatory) 기사를 요약한 내용입니다.https://insights.citeline.com/pink-sheet/compliance/distribution-supply-chain/pharma-still-nervous-while-riding-trumps-tariff-rollercoaster-DFQMWLGXSZBS3K34UY2OE6TUVA/Playlist: soundcloud.com/citelinesounds/sets/korean-language-bio…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pharma stocks had a turbulent day after Trump's tariff pause, with some stocks making a late-day recovery. However, there are concerns about potential FDA budget cuts that could severely impact drug access in the US. Biot…
  continue reading
 
Today’s episode is a wake-up call for pharma marketers launching telehealth campaigns. If you're using AI voice assistants or call automation tools in your outreach, you could be stepping into a legal minefield under California’s privacy law (CCPA & CIPA). Your telehealth campaign reflects your brand—don’t let privacy lawsuits define it. Contact th…
  continue reading
 
Recently on Relentless Health Value, we’ve been tinkering around with a few recurring themes—recurring through lines—that are just true about American healthcare these days. In this episode of Relentless Health Value, host Stacey Richter speaks with Dr. Christine Hale about high cost claimants and the implications for healthcare plans in 2025 and b…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. President Trump's announcement of 'major' pharmaceutical tariffs has caused market turmoil and a decrease in industry value. Analysts predict increased costs for medicines and potential negative effects on patient drug acc…
  continue reading
 

Quick Reference Guide

Listen to this show while you explore
Play